Larry Nichter
Surgery of the Hand · Huntington Beach, CANPI 1710062336
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.4%), grants and speaking fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 68.5% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $2,690, 3.3 times the $820 reported in 2019.
Across 137 payments — averaging $59.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Sientra, Inc.$1K
- Mentor Worldwide LLC$399
- Kerecis Limited$254
- Pacira Pharmaceuticals Incorporated$160
- Davol Inc.$131
- plus $462 from 9 others
Across 2 payments — averaging $725.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
What the payments were for
- Speaking & faculty fees$1,56919%
- Grants$1,75022%
- Food & beverage$4,74558%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 102 | $5,570 |
| Sientra, Inc. | 11 | $1,153 |
| Mentor Worldwide LLC | 6 | $399 |
| Kerecis Limited | 1 | $254 |
| Pacira Pharmaceuticals Incorporated | 2 | $160 |
| Davol Inc. | 2 | $131 |
| TELA Bio, Inc. | 2 | $95 |
| Merz North America, Inc. | 1 | $90 |
| Motiva USA, LLC | 2 | $87 |
| Acelrx Pharmaceuticals, Inc. | 1 | $73 |
| Apyx Medical Corporation | 2 | $34 |
| Galderma Laboratories, L.p. | 2 | $29 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Tepha Inc | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,130 in reported general payments places this provider in the 80th percentile of 76 surgery of the hand providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $164 |
| Ondansetron OdtOndansetron | 11 | $58 |
| Cefadroxil | 17 | $31 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Huntington Beach
- Bauback SafaSan Francisco$172K
- Emily Perezla Mirada$56K
- Joshua GluckVentura$26K
- Howard SutkinLos Gatos$22K
- Aaron BergerOakland$14K
- Nicole ConklingOrange$14K
- Marie DuschSanta Maria$11K
- Andre IshakOxnard$11K
- Alfonso CamberosSan Diego$10K
- James ColemanOrange$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.